Concepedia

A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors

A. S. T. Planting, Pieter Sonneveld, Ate van der Gaast, Alex Sparreboom, M.E.L. van der Burg, Gregorius P. M. Luyten, K. De Leeuw, M de Boer-Dennert, Paul Wissel, Roxanne C. Jewell,

Cancer Chemotherapy and Pharmacology · 2004 · 106 citations · 29 references

DOI

Concepts

References

29

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

Sandra M. Swain, Fredrick S. Whaley, Mirjam C. Gerber et al. · Journal of Clinical Oncology · 1997 · 652 citations

, , +16

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

William S. Dalton, Thomas M. Grogan, Paul S. Meltzer et al. · Journal of Clinical Oncology · 1989 · 560 citations

, , +15

Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.

Luca Gianni, Elisabetta Munzone, Giuseppe Capri et al. · Journal of Clinical Oncology · 1995 · 559 citations

, , +17

In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.

François Hyafil, Catherine Vergely, Philippe Vignaud et al. · PubMed · 1993 · 529 citations

, , +11

Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis [see comments]

Lydia Campos, Denis Guyotat, E Archimbaud et al. · Blood · 1992 · 496 citations · Full text

, , +16